Even though mixed tumors were not regressed like as TUBO homogenous tumor, but anti-neu antibody therapy significantly delayed tumor growth (p = 0.014) and increased mouse survival (p < 0.001) when the heterogeneic ratio was 10,000:1 (0.001%). This evidence concerns the gene ERBB2 and neoplasm.